InspireMD, Inc.
NSPR
$1.94
-$0.04-2.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -61.06% | -66.28% | -58.79% | -69.73% | -52.38% |
| Total Depreciation and Amortization | 82.86% | 62.12% | 42.03% | 22.95% | 20.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 69.25% | 38.30% | 14.52% | 54.49% | 42.86% |
| Change in Net Operating Assets | 1,725.00% | 26.63% | 3.57% | 347.06% | 95.25% |
| Cash from Operations | -51.46% | -91.39% | -73.62% | -61.60% | -40.98% |
| Capital Expenditure | 21.85% | -21.26% | -84.10% | -44.65% | -338.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 242.92% | -1.39% | -58.88% | 4,759.66% | -184.90% |
| Cash from Investing | 227.46% | -3.34% | -64.67% | 22,994.44% | -192.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -88.03% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -312,500.00% | -- | -- | -- | -- |
| Cash from Financing | 5,584.56% | -88.03% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 127.27% | 100.00% | 1,375.00% | 207.14% | 144.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 512.94% | -104.60% | -2,502.79% | 173.78% | -647.82% |